The Clorox Company $CLX Shares Sold by Cwm LLC

Key Points

• Cwm LLC cut its stake in The Clorox Company by 42.1%, selling 17,099 shares and leaving it with 23,503 shares worth about $2.37 million, while institutional investors own roughly 78.53% of the stock.
• Wall Street sentiment has turned cautious: the consensus rating is "Reduce" with a consensus target of $111.33, and several firms (including Citigroup, Morgan Stanley and JPMorgan) have lowered price targets or maintained underweight/neutral views.
• Clorox declared a quarterly dividend of $1.24 (annualized $4.96) for a 5.0% yield$1.39 (miss) and revenue down 0.8% YoY.

Cwm LLC decreased its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 42.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 23,503 shares of the company's stock after selling 17,099 shares during the quarter. Cwm LLC's holdings in Clorox were worth $2,370,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. ProShare Advisors LLC lifted its stake in shares of Clorox by 11.7% in the 3rd quarter. ProShare Advisors LLC now owns 1,297,016 shares of the company's stock valued at $159,922,000 after purchasing an additional 136,135 shares during the last quarter. Vanguard Personalized Indexing Management LLC increased its position in shares of Clorox by 64.2% during the third quarter. Vanguard Personalized Indexing Management LLC now owns 25,732 shares of the company's stock valued at $3,173,000 after acquiring an additional 10,065 shares during the last quarter. JPMorgan Chase & Co. increased its position in shares of Clorox by 27.0% during the third quarter. JPMorgan Chase & Co. now owns 928,654 shares of the company's stock valued at $114,506,000 after acquiring an additional 197,330 shares during the last quarter. Brookstone Capital Management increased its position in shares of Clorox by 1,395.4% during the third quarter. Brookstone Capital Management now owns 94,332 shares of the company's stock valued at $11,631,000 after acquiring an additional 88,024 shares during the last quarter. Finally, Eliot Finkel Investment Counsel LLC acquired a new stake in shares of Clorox during the third quarter valued at about $1,697,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the stock. BNP Paribas Exane upgraded shares of Clorox from an "underperform" rating to a "neutral" rating in a research report on Wednesday, February 11th. Citigroup decreased their price target on Clorox from $115.00 to $110.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 15th. Morgan Stanley decreased their price target on Clorox from $136.00 to $110.00 and set an "equal weight" rating on the stock in a research note on Wednesday. TD Cowen lifted their target price on Clorox from $98.00 to $111.00 and gave the company a "hold" rating in a research report on Tuesday, March 31st. Finally, JPMorgan Chase & Co. reaffirmed an "underweight" rating and issued a $99.00 target price (down from $117.00) on shares of Clorox in a research report on Friday, April 17th. One equities research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of "Reduce" and a consensus target price of $111.33.

Clorox Stock Up 1.0%

Shares of NYSE CLX opened at $98.68 on Friday. The stock has a market cap of $11.93 billion, a P/E ratio of 16.12, a PEG ratio of 0.48 and a beta of 0.65. The company has a current ratio of 0.74, a quick ratio of 0.48 and a debt-to-equity ratio of 71.03. The Clorox Company has a 12-month low of $96.58 and a 12-month high of $143.96. The business's fifty day simple moving average is $110.40 and its 200-day simple moving average is $109.48.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.43 by ($0.04). The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 11.17% and a return on equity of 383.01%. The firm's revenue was down .8% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.55 earnings per share. As a group, equities analysts predict that The Clorox Company will post 5.87 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 8th. Stockholders of record on Wednesday, April 22nd will be given a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, April 22nd. This represents a $4.96 dividend on an annualized basis and a dividend yield of 5.0%. Clorox's payout ratio is currently 81.05%.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.